BCL2L1 and breast carcinoma: Despite this, few studies have focused on inhibition of antiapoptotic proteins in combination with radiotherapy, and none have specifically examined Bcl-xL inhibition in combination with radiotherapy in the treatment of aggressive breast cancers (35).